Randomized Study Versus Placebo for the Prevention of Neurotoxicity Induced by Weekly PACLITAXEL
Clinical trial NCT05695313 · UNKNOWN
Trial details
- NCT number
- NCT05695313
- Sponsor
- Centre Georges Francois Leclerc
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-12
- Primary completion
- 2026-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.